Navigation Links
MBS Value Partners Hires Two New Senior Staff Members
Date:2/8/2010

NEW YORK, Feb. 8 /PRNewswire/ -- MBS Value Partners, a strategic communications firm specializing in investor relations and corporate communications for domestic and international clients, announced today that Lisa Lettieri and Matthew Haines have joined as Managing Directors.

“Lisa and Matt bring outstanding senior-level advisory and corporate experience that will serve our clients well,” said Lynn Morgen, co-founder of MBS. “Lisa’s and Matt’s significant experience in clean technology and health care / biotechnology, respectively, complement our existing expertise in technology, business/industrial services, media and consumer businesses, and will enable us to further leverage our knowledge base, network of financial community relationships and crisis expertise for the benefit of our clients."

Lisa Lettieri brings more than a dozen years of integrated corporate communications and strategic planning experience to MBS. Most recently she headed Investor Relations and Corporate Communications for FuelCell Energy, a Nasdaq-listed manufacturer of high-efficiency ultra-clean power plants headquartered in Danbury, Connecticut. Prior to that she was Vice President of Investor Relations at Champion Enterprises, Inc., a factory homebuilder and was previously Director of Corporate Communications with responsibility for investor relations at Scientific Games Corporation. Lisa was an institutional investment professional for 15 years prior to becoming a corporate communications specialist. She holds a BS in Marketing from Manhattan College and an MBA in Finance from Fordham University in New York.

Matt Haines brings more than 20 years of investor relations, media relations, and corporate communications experience in health care and biotechnology. Prior to joining MBS, Matt served as Senior Director of Investor Relations and Corporate Communications at MDRNA, Inc., a biotechnology company developing RNAi therapeutics and delivery systems. Earlier, Matt served as Senior Director of Investor Relations and Corporate Communications at Nastech Pharmaceutical Company Inc. and as Director of Corporate Communications at OSI Pharmaceuticals, Inc. Matt's career includes almost 10 years of health care agency experience in increasingly responsible positions. Matt holds a BA in Political Science from New York University and an MBA in Marketing from NYU's Stern School of Business.

ABOUT MBS VALUE PARTNERS

MBS Value Partners, headquartered in New York City, is a strategic communications firm that provides senior level advisory work and customized investor relations, financial media and corporate communications programs for a growing roster of domestic and international clients. For additional information, please visit www.mbsvalue.com.

SOURCE MBS Value Partners

RELATED LINKS
http://www.mbsvalue.com

'/>"/>

SOURCE MBS Value Partners
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Medco Announces Agreement to Acquire Diabetes Care Leader PolyMedica in Transaction Valued at $1.5 Billion
2. Sunesis Pharmaceuticals Announces Reorganization to Focus Resources and Build Value in Clinical-Stage Programs
3. Industry Executives Finding Value in Shift of Scientific Publications
4. Top Health Care Economists and Physician-Innovators Discuss Value of Medical Technology at AdvaMed 2007 Conference
5. Caliper Life Sciences Awarded National Institute of Environmental Health Services Contract Valued to $7.0 Million
6. ValueRich Report on AMDL/China Available on Web Site
7. Baxter and Novation Sign Multi-Year Contract Extension Valued at Over $200 Million for Medication Delivery Products
8. AMDL Expands Drug Distribution in China With Additional Agreement, Valued at $2.3 Million Annually
9. Synvista Therapeutics Highlights Newly Published Data Demonstrating the Value of Haptoglobin Genotype Testing In People with Diabetes
10. Takeda to Acquire Millennium for US$25.00 Per Share in an All Cash Tender Offer Valued at $8.8 Billion
11. Industry Executives Finding Value in Shift of Scientific Publications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... Mass. , June 23, 2016   ... development of novel compounds designed to target cancer ... napabucasin, has been granted Orphan Drug Designation from ... the treatment of gastric cancer, including gastroesophageal junction ... stemness inhibitor designed to inhibit cancer stemness pathways ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... and Mold) microbial test has received AOAC Research Institute approval 061601. , “This ... introduced last year,” stated Bob Salter, Vice President of Regulatory and Industrial Affairs. ...
(Date:6/23/2016)... ... June 23, 2016 , ... Supplyframe, the Industry ... Supplyframe Design Lab . Located in Pasadena, Calif., the Design Lab’s mission ... hardware projects are designed, built and brought to market. , The Design Lab ...
(Date:6/23/2016)...  Blueprint Bio, a company dedicated to identifying, protecting ... has closed its Series A funding round, according to ... "We have received a commitment from Forentis Fund that ... meet our current goals," stated Matthew Nunez . ... complete validation on the current projects in our pipeline, ...
Breaking Biology Technology:
(Date:5/9/2016)... 2016 Elevay is currently known ... freedom for high net worth professionals seeking travel for ... connected world, there is still no substitute for a ... sealing your deal with a firm handshake. This is ... advantage of citizenship via investment programs like those offered ...
(Date:4/26/2016)... and LONDON , ... Finacle, part of EdgeVerve Systems, a product subsidiary ... Onegini today announced a partnership to integrate the ...      (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ) ... provide their customers enhanced security to access and ...
(Date:4/15/2016)... -- Research and Markets has announced the ...  report to their offering.  ,      ... gait biometrics market is expected to grow at ... Gait analysis generates multiple variables such ... compute factors that are not or cannot be ...
Breaking Biology News(10 mins):